CD8A and esophageal squamous cell carcinoma: (74) analyzed indoleamine 2,3-dioxygenase 1 (IDO1), CD8+, and PD-L1 expression in 138 patients with ESCC who underwent nCRT and esophagectomy without achieving complete pathologic response were included for analysis.